Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financing and Plans to List on Nasdaq Through Merger with Health Sciences Acquisitions Corporation 2
Benzinga
JULY 5, 2022
Investors in $110 million Series D financing include Medtronic and Terumo as well as lead investor RTW Investments and founding investor Perceptive Advisors. The Series D financing was not contingent on the consummation of the Business Combination. NEW HOPE, Pa.
40 
Let's personalize your content